Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Pediatr. 2012 Jul 19;162(1):94–100. doi: 10.1016/j.jpeds.2012.06.009

Table 2.

Blood level measurements by BMI and blood pressure groups - categorical variables: frequencies (percents); continuous variables: mean (SD) or geometric mean [1st quartile, 3rd quartile]

N-NBP
(N = 111)
N-HBP
(N = 35)
O-NBP
(N = 103)
O-HBP
(N = 52)
4-
Group
p-value
2-
Group
p-value
Fasting Glucose
(mg/dl)
95.5 ( 8.5) 96.4 ( 7.8) 98.4 (13.5) 97.4 ( 8.3) 0.402 0.774
Glucose 2 hr (mg/dl) 1 12.3 (21.7) 115.4 (22.9) 123.1 (41.8) 121.3 (23.1) 0.090 0.410
Fasting Insulin
(uU/ml)
5.1 [3.6, 7.2] 5.7 [4.0, 7.3] 10.6 [6.6, 16.9] 13.2 [9.7, 17.4] <.001 <.001
Insulin 2 hr (uU/ml) 39.7 [26.4, 62.2] 33.8 [19.5, 65.1] 55.4 [34.9,
103]
69.1 [42.8,
110]
<.001 0.006
HOMA (mg/dl) 1.19 [0.84, 1.71] 1.33 [0.91, 1.86] 2.56 [1.57, 3.17 [2.30, <.001 <.001
4.09] 4.45]
HDL (mg/dl) 58.1 (12.0) 57.0 (13.4) 48.8 (11.3) 45.3 ( 9.6) <.001 <.001
LDL (mg/dl) 85.0 (23.5) 83.2 (25.1) 91.2 (29.6) 94.8 (27.1) 0.151 0.166
Triglycerides (mg/dl) 5 4 . 4 [43.0, 69.0] 60.7 [48.0, 76.0] 66.2 [52.0, 71.7 [56.5, <.001 0.016
88.0] 87.5]
Total Cholesterol
(mg/dl)
155.0 (27.6) 154.9 (31.2) 154.7 (31.7) 156.4 (31.1) 1.000 0.818
UAE (mg/gm creat) 2.79 [1.21, 6.11] 2.61 [1.13, 5.20] 2.30 [0.93, 2.27 [1.15, 0.746 0.599
4.61] 3.54]
Adiponectin (ug/ml) 6.8 [4.7, 11.1] 6.4 [3.8, 12.2] 4.6 [3.4, 7.1] 4.8 [3.3, 7.2] <.001 0.205
IL6 (pg/ml) 2.3 [1.7, 2.8] 3.0 [2.1, 4.1] 3.0 [2.2, 4.0] 2.9 [2.1, 4.1] 0.004 0.410
PAI1 (ng/ml) 44.5 (19.9) 47.2 (23.6) 71.7 (23.4) 78.8 (31.2) <.001 <.001
TNFα (pg/ml) 8.2 [7.0, 9.4] 8.3 [7.4, 8.9] 8.0 [6.8, 9.5] 8.2 [6.6, 9.0] 0.979 0.937
TNFα Receptor
(Pg/ml)
0.8 [0.6, 1.0] 0.9 [0.7, 1.1] 1.0 [0.8, 1.2] 1.0 [0.8, 1.2] 0.010 0.022
hsCRP (mg/dl) 0.4 [0.2, 0.7] 0.4 [0.2, 1.0] 1.4 [0.6, 3.5] 1.4 [0.6, 3.1] <.001 <.001
Metabolic Syndrome 0 (0%) 1 ( 3%) 15( 15%) 31 (60%) <.001 <.001

Fishers exact test (categorical) or ANOVA F-test (continuous): any groups different (4-group) and O-HBP vs. others combined (2-group). Adjustments made for multiple comparisons and false discovery rate.

Data natural log transformed: geometric means with [first quartile, third quartile] presented

UAE: creatinine-corrected urinary albumin excretion; N-NBP: non-obese normal BP; N-HBP: non-obese high BP; O-NBP: obese normal BP; O-HBP: obese normal BP;

Metabolic Syndrome: 3 or more of following: BMI Percentile > 95; SBP >120 or DBP >80; HDL <40 (males) or <50 (females); Triglycerides >110; Fasting glucose >110